Pancreas & Related Cancers: Emerging Topics in 2025

Through didactic lectures, case based presentations, and lively discussion with expert faculty, participants will review of the latest technologies and procedures and will be able to improve their delivery of care, determine the need for referrals sooner, and achieve better patient outcomes. The ultimate goal of this conference is improve the care of patients with pancreatic and related cancers by focusing on improvements to the diagnostic methods, treatment strategies, and supportive care.

Successful Completion
To successfully complete this activity, the required evaluation must be completed no later than Thursday, July 3, 2025. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.

1. Assess the current state of pancreatic cancer in the US and the challenges associated with diagnosis, management, and treatment of this disease.
2. Appraise the role of the gastroenterologist in the diagnosis, screening, testing, and management.
3. Evaluate the surgical treatment options available and the risks and benefits associated with each.
4. Examine the pathology of pancreas cancer in terms of its specific nomenclature and future progress.
5. Analyze the various neoadjuvant and adjuvant therapies available, and the applications, implications, and outcomes of these treatment strategies.
6. Discuss the current novel treatment strategies for locally advanced pancreatic cancer.
7. Describe therapies used in the treatment of pancreatic cancer such as post-resection and radiation.
8. Assess the value of supportive care and emotional support in treating the cancer patient.
9. Identify the tools available to counsel cancer patients to meet their individual needs.
10. Describe the molecular underpinnings and drivers of pancreatic cancer.
11. Identify the appropriate imaging studies for the initial evaluation of patients presenting pancreas cancer pathology.
12. Evaluate the various noninvasive imaging including CT, MRI, PET, etc.
13. Examine the benefits of palliative therapies such as pharmacologic cytotoxicity and alternative treatment methods.
14. Apply relationship-building values and the principles of collaboration to the care for patients with pancreatic cancer.

In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: This educational activity is designated for a maximum of 4.00 AMA PRA Category 1 Credits ^TM . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses: This activity awards 4.00 nursing contact hours.

Other Healthcare Professionals: This educational activity is designated for 4.00 AMA PRA Category 1 Credit ^TM. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Agenda
Agenda subject to change without notice.

Cancellation Policy
Requests for refunds must be submitted in writing and received in the Office of CPD two weeks prior to the start date of the course. There will be no refunds after this period.*  Cancellations notified before the two week time frame will incur a 25% administration fee (with a minimum of $20).  Registrants who fail to attend the conference are responsible for the entire fee.  All refunds will be processed after the conference.  The University reserves the right to cancel or postpone this course due to unforeseen circumstances.  In the event of cancellation or postponement, the University will refund registration fees, but is not responsible for related costs or expenses to participants, including cancellation fees assessed by hotels, airlines or travel agencies. 

*Registration fees will be refunded less a 15% administration fee to international conference registrants who are unable to secure a travel visa. Registrants must provide proof of visa denial. 

 Jefferson Release Policy
Jefferson may record/livestream/photograph this educational activity. These images/recordings, along with your name, may be used in Jefferson publications or on the Jefferson website. If you verbally submit any questions for Q&A sessions, you are agreeing to be recorded and to have that recording available in enduring materials. Once photographed, filmed, recorded, or videotaped, you waive the right of inspection or approval to which such images/recordings may be put and Jefferson has the right to use, publish, reproduce, modify, adapt, and distribute at any time in any manner or medium.

Jefferson HIPAA Policy
As an attendee of this educational activity hosted by Thomas Jefferson University, Jefferson University Physicians, and Thomas Jefferson University Hospitals, Inc. (collectively 'Jefferson'), you may gain access to certain proprietary information ('Confidential Information'), including Protected Health Information ('PHI').

By participating in this educational activity, you agree to maintain the confidentiality of all Confidential Information, including all PHI, obtained from any source. You also agree to take all necessary steps to protect such Confidential Information and shall not directly or indirectly disclose or use it in any manner or for any reason, other than as necessary to complete the educational activity. Further, you agree not to take photographs, record in any manner or otherwise reproduce any such Confidential Information. You understand that any unauthorized use or disclosure of Confidential Information may result in possible legal action against you by Jefferson whose confidentiality is breached.

Photography and Recording
Unauthorized recording or photography at a Jefferson-sponsored event is strictly prohibited. Individuals found violating this policy will be asked to vacate the activity. No credits or refund will be issued.

Copyright
All rights reserved – Thomas Jefferson University. No part of this program may be used, reproduced, or shared in any manner whatsoever without express written permission, except in the case of brief quotations embodied in articles or reviews.

Mitigation of Relevant Financial Relationships

Thomas Jefferson University adheres to the Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards.

All planners, faculty, and others in control of educational content are required to disclose any relevant financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity. Such disclosures will be available prior to the start of the activity. Jefferson conflict of interest mitigation process may result in changes to the program agenda.

Off-Label/Investigational Use
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).

Content Disclaimer
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Harish Lavu, MD
Professor of Surgery
Thomas Jefferson University
Philadelphia, PA

Co-Director, Faculty

Nothing to disclose

Pramila R Anne, MD
Associate Professor, Director of Clinical Operations, Department of Radiation Oncology
Thomas Jefferson University
Philadelphia, PA

Faculty

Nothing to disclose

Babar Bashir, MD, FACP
Assistant Professor
Thomas Jefferson University Hospital
Philadelphia, PA

Faculty

Advisor-Tempus, AI|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Merck (Any division) (Relationship has ended)|Grant or research support-Amgen, Inc.|Grant or research support-Bicycle Therapeutics|Grant or research support-Artios Pharma|Grant or research support-Elucida Oncology|Grant or research support-Gritstone Bio|Grant or research support-Ikena Oncology|Grant or research support-Jazz Pharmaceuticals|Grant or research support-KAHR Medical|Grant or research support-Lyell Immunopharma|Grant or research support-Merck (Any division)|Grant or research support-Pionyr Immunopharma|Grant or research support-RASCAL Therapeutics

Aditi Jain, PhD
Research Instructor
Thomas Jefferson University
Philadelphia, PA

Faculty

Wei Jiang, MD, PhD
Associate Professor
Thomas Jefferson University Hospital
Philadelphia, PA

Faculty

Nothing to disclose

Anand Kumar, MD, MPH
Associate Professor of Medicine
Thomas Jefferson University
Philadelphia, PA

Faculty

Consulting Fee-Olympus Corporation|Consulting Fee-Boston Scientific Corporation

Avinoam Nevler, MD
Assistant Professor
Thomas Jefferson University
Philadelphia, PA

Faculty

Monika Shirodkar, MD
Associate Professor of Clinical Medicine
Thomas Jefferson University Hospital
Philadelphia, PA

Faculty

Nothing to disclose

Jacqueline Stulb, RD, CSO, LDN
Registered Dietitian
Thomas Jefferson University
Philadelphia, PA

Faculty

Nothing to disclose

Charles J Yeo, MD, FACS
Chair & Samuel D. Gross Professor
Thomas Jefferson University Hospital Department of Surgery
Philadelphia, PA

Faculty

Nothing to disclose

Richard Zheng, MD, MHS, MS
Assistant Professor
Thomas Jefferson University Hospital
Philadelphia, PA

Faculty

Nothing to disclose

Eika Barriera-Justiniano, CRNP
Nurse Practitioner
Thomas Jefferson University
Philadelphia, PA

Faculty, Nurse Planner

Nothing to disclose

Nicole Pocetti, CRNP
Nurse Practitioner
Thomas Jefferson University
Philadelphia, PA

Faculty, Nurse Planner

Nothing to disclose

Chrystyna Pospolyta, MPH
Project Manager
Thomas Jefferson University
Philadelphia, PA

OCPD Team Member

Nothing to disclose

Friday, June 13, 2025

Exhibitor Rules

• Exhibitor is not providing commercial support for this educational activity. Exhibitor is purchasing exhibit space.
• Exhibits are intended for informational purposes, products should not be sold through the exhibit hall.
• TJU and the exhibitor acknowledge and agree that the exhibitor may be subject to Section 6002 of the Affordable Care Act, which added Section 1128G to the Social Security Act, and its implementing regulations codified in 42 CFR 402 &403 (Collectively the Sunshine Act). Exhibiting companies are solely responsible for collecting any information about actions within their virtual exhibit space that constitutes a payment or transfer of value to a covered participant, which is required to reported under the Sunshine Act.
• Exhibitors may observe educational sessions but must refrain from participating in the activity.
• No recordings of the scientific sessions on behalf of the exhibitor's company is permitted.

Application Deadline
Applications for exhibits will be accepted through May 16, 2025. After May 16, 2025, applications may be accepted on a case by case basis.
 
Cancellation and Refunds
In the event that the symposium is canceled by the organizers, exhibit fees will be refunded in full, however Thomas Jefferson University is not responsible for other expenses incurred by the exhibitor.
 
In the event an exhibitor cancels participation, refunds will be made as follows:

• Prior to the deadline of May 16, 2025 a refund will be given minus a 10% administration fee.
• After May 16, 2025 no refund will be given.
• Exhibitors who are absent from the conference will not receive a refund.
• Exhibit cancellations must be made in writing.
  Send cancellation notice to [email protected] and include name of activity in subject line.